Virbac Offers RVNs The Opportunity To Take A Greater Role In Neutering
With pressure on veterinary services higher than ever, Virbac are pleased to clarify that Suprelorin, the non-surgical alternative for neutering male dogs, may be implanted by registered veterinary nurses (RVNs) under the direction of a veterinary surgeon under schedule 3 of the Veterinary Surgeons Act.
To support veterinary nurses in taking a greater role in neutering, Virbac are pleased to announce a complementary 2-part webinar series this December featuring some top class speakers and some light-hearted Christmas fun!
The first webinar titled “The Science of Canine Castration and Practical Tips for Clinics” will be presented by Dr Michelle Kutzler and Nicola Lakeman on Thursday 9th December 2021 at 7:30pm; followed by an online mixology course to create a bit of your own Christmas sparkle. This webinar is available for registration at: tinyurl.com/virbac-rvn
The second webinar titled “Behaviour in Post-Pandemic Puppies and Practical Tips for Clinics” will be presented by Stephanie Hedges and Nicola Lakeman on Thursday 9th December 2021 at 7:30pm. The webinar will be followed by our first ‘Quizmas’ hosted by former Love Islander Chris Taylor. This webinar is available for registration at: tinyurl.com/virbac-rvn2
‘A huge surge in dog ownership in the last two years, combined with the additional pressures of COVID-19, has massively increased pressures on veterinary teams’ explains Dr Neil Mottram MRCVS, Technical Product Manager at Virbac. ‘At the same time we know that pet owner attitudes to surgical neutering is changing with 1 in 3 pet owners saying that they would look at alternative methods to surgical castration1. Suprelorin offers practices the opportunity to utilise the skills of their RVNs to provide a choice to clients when it comes to neutering and help to ease pressures on surgical waiting lists’.
SUPRELORIN® is a sustained release implant containing deslorelin (a GnRH super agonist) and is licensed for use in healthy, sexually mature dogs that have not been neutered to make them temporarily infertile. The implant is inserted subcutaneously, under the loose skin on the back between the lower neck and the lumbar area. Conveniently, implantation is a quick procedure and does not require anaesthesia or hospitalisation.
SUPRELORIN® is available in two presentations, a 4.7mg implant which lasts for at least 6 months and a 9.4mg implant which lasts for at least 12 months in dogs.
For more information on SUPRELORIN®, or any of the other products in the Virbac reproduction portfolio, please speak to your Virbac Territory Manager.
1. Harris interactive. Understanding the usages & attitudes around cats & dogs sterilization and evaluating the potential of Suprelorin. (2017).
More from Virbac Animal Health
- Virbac Launches Innovative New Pet Food Business Model for Veterinary Practices
- Virbac & BattLab/Laboklin Offer Canine Mast Cell Tumour Webinar Series
- Virbac Launches ‘Lumps and Bumps’ Toolkit for Practices
- New atopy claim for Cortavance with up to 28 days use!
- Virbac welcomes Clomicalm & Itrafungol to its extensive companion animal range